5-(Bromomethyl)-2-(trifluoromethyl)pyridine, 95.0%, 250mg

(2E)-3-[4-(benzyloxy)phenyl]-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

methyl 3-{[2-(piperidin-1-yl)ethyl]amino}butanoate, 95.0%, 2g

3,3-Dichloro-1-(4-iodophenyl)piperidin-2-one, 97%, 5g

4'-Propoxyacetophenone>98.0%(GC)5g

Methyl 2-amino-2-(3,4-dimethylphenyl)acetate, 95%, 100mg

1-(3-Cyanopyridin-2-yl)piperidine-4-carboxylic acid, 1g

methyl 4-oxo-1,4-dihydropyridine-2-carboxylate hydrochloride, 98%, 1g

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Diisopropilammina, minimo 99,5%, per sintesi, 10 l, banda stagnata

2-Bromothiazole-5-carboxamide, 95.0%, 250mg

2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate, 95.0%, 100g

Boc-Trp(Boc)-OH, 98%, 5g